First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial - Archive ouverte HAL Access content directly
Journal Articles The Lancet Year : 2017

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial

, , , , , , , , , , , , , , (1) , , , , , , , , , , , , , , , , , , , , , ,
1
Pascal Joly
  • Function : Author
Maud Maho-Vaillant
Catherine Prost-Squarcioni
  • Function : Author
Vivien Hebert
  • Function : Author
Estelle Houivet
  • Function : Author
Sébastien Calbo
  • Function : Author
Frédérique Caillot
  • Function : Author
Marie Laure Golinski
  • Function : Author
Bruno Labeille
  • Function : Author
Catherine Picard-Dahan
  • Function : Author
Carle Paul
  • Function : Author
Marie-Aleth Richard
Jean David Bouaziz
  • Function : Author
Sophie Duvert-Lehembre
  • Function : Author
Philippe Bernard
  • Function : Author
Immuno-Régulation dans les Maladies Auto-Immunes Inflammatoires et le Cancer - EA 7509
Frederic Caux
  • Function : Author
Marina Alexandre
  • Function : Author
Saskia Ingen-Housz-Oro
  • Function : Author
Pierre Vabres
Emmanuel Delaporte
  • Function : Author
Gaelle Quereux
  • Function : Author
Alain Dupuy
  • Function : Author
Sebastien Debarbieux
  • Function : Author
Martine Avenel-Audran
  • Function : Author
Michel d'Incan
  • Function : Author
Christophe Bedane
  • Function : Author
Nathalie Bénéton
  • Function : Author
Denis Jullien
  • Function : Author
Nicolas Dupin
  • Function : Author
Laurent Misery
Laurent Machet
Marie Beylot-Barry
Olivier Dereure
Bruno Sassolas
  • Function : Author
Thomas Vermeulin
  • Function : Author
Jacques Benichou
  • Function : Author
Philippe Musette
  • Function : Author

Domains

Life Sciences [q-bio] Human health and pathology

Arnaud Pommier  : Connect in order to contact the contributor

https://hal.univ-reims.fr/hal-03604991

Submitted on : Thursday, March 10, 2022-5:17:48 PM

Last modification on : Friday, March 11, 2022-3:12:35 AM

Not file

Dates and versions

hal-03604991 , version 1 (10-03-2022)

Identifiers

Cite

Pascal Joly, Maud Maho-Vaillant, Catherine Prost-Squarcioni, Vivien Hebert, Estelle Houivet, et al.. First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial. The Lancet, 2017, 389 (10083), pp.2031-2040. ⟨10.1016/S0140-6736(17)30070-3⟩. ⟨hal-03604991⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

URCA IRMAIC
2 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More